Baxter
BAX
#1157
Rank
โ‚น1.286 T
Marketcap
โ‚น2,509
Share price
-6.43%
Change (1 day)
-30.47%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

P/E ratio for Baxter (BAX)

P/E ratio as of April 2025 (TTM): 6.12

According to Baxter's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.12305. At the end of 2022 the company had a P/E ratio of -10.6.

P/E ratio history for Baxter from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-10.6-131.47%
202133.5-9.74%
202037.1-12.93%
201942.793.81%
201822.0-55.05%
201749.0901.7%
20164.89-77.3%
201521.5148.79%
20148.65-15.24%
201310.219%
20128.5824.82%
20116.87-39.5%
201011.429.75%
20098.76-2.84%
20089.01-24.26%
200711.91.52%
200611.7-11.17%
200513.2-55.7%
200429.8169.46%
200311.1-7.47%
200211.9-53.46%
200125.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
136 2,116.75%๐Ÿ‡บ๐Ÿ‡ธ USA
54.1 782.90%๐Ÿ‡บ๐Ÿ‡ธ USA
120 1,861.80%๐Ÿ‡บ๐Ÿ‡ธ USA
39.9 552.06%๐Ÿ‡บ๐Ÿ‡ธ USA
35.6 481.18%๐Ÿ‡บ๐Ÿ‡ธ USA
30.6 400.42%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
-6.66-208.75%๐Ÿ‡บ๐Ÿ‡ธ USA
32.3 427.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-70.1-1,244.60%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.